ALPHATEC HOLDINGS, INC. Operating Expenses
ALPHATEC HOLDINGS, INC. (ATEC) reported Operating Expenses of $156.01 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-04
- ALPHATEC HOLDINGS, INC. operating expenses for the quarter ending 2026-06-30 was $156.01M, a 9.72% increase year-over-year.
- ALPHATEC HOLDINGS, INC. operating expenses for the quarter ending 2026-03-31 was $159.06M, a 0.77% decline year-over-year.
- ALPHATEC HOLDINGS, INC. operating expenses for the quarter ending 2025-12-31 was $158.31M, a 8.87% increase year-over-year.
- ALPHATEC HOLDINGS, INC. operating expenses for the quarter ending 2025-09-30 was $153.23M, a 12.31% increase year-over-year.
- ALPHATEC HOLDINGS, INC. operating expenses for fiscal 2025 was $614.02M, a 9.56% increase from fiscal 2024.
- ALPHATEC HOLDINGS, INC. operating expenses for fiscal 2024 was $560.43M, a 15.89% increase from fiscal 2023.
- ALPHATEC HOLDINGS, INC. operating expenses for fiscal 2023 was $483.60M, a 27.25% increase from fiscal 2022.
- ALPHATEC HOLDINGS, INC. operating expenses for fiscal 2022 was $380.03M, a 32.96% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $156.01M 10-Q · filed 2026-08-04 | $315.06M 10-Q · filed 2026-08-04 | $473.37M derived: sum of 3 quarters · filed 2026-08-04 | $626.61M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $159.06M 10-Q · filed 2026-05-05 | $317.37M derived: sum of 2 quarters · filed 2026-05-05 | $470.60M derived: sum of 3 quarters · filed 2026-05-05 | $612.79M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $158.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $311.54M derived: sum of 2 quarters · filed 2026-02-24 | $453.73M derived: sum of 3 quarters · filed 2026-08-04 | $614.02M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $153.23M 10-Q · filed 2025-10-30 | $295.42M derived: sum of 2 quarters · filed 2026-08-04 | $455.71M 10-Q · filed 2025-10-30 | $601.11M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $142.19M 10-Q · filed 2026-08-04 | $302.47M 10-Q · filed 2026-08-04 | $447.88M derived: sum of 3 quarters · filed 2026-08-04 | $584.31M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $160.29M 10-Q · filed 2026-05-05 | $305.69M derived: sum of 2 quarters · filed 2026-05-05 | $442.13M derived: sum of 3 quarters · filed 2026-05-05 | $580.03M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $145.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $281.84M derived: sum of 2 quarters · filed 2026-02-24 | $419.74M derived: sum of 3 quarters · filed 2026-02-24 | $560.43M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $136.43M 10-Q · filed 2025-10-30 | $274.33M derived: sum of 2 quarters · filed 2025-10-30 | $415.02M 10-Q · filed 2025-10-30 | $555.04M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $137.90M 10-Q · filed 2025-07-31 | $278.59M 10-Q · filed 2025-07-31 | $418.61M derived: sum of 3 quarters · filed 2026-02-24 | $537.02M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $140.69M 10-Q · filed 2025-05-01 | $280.71M derived: sum of 2 quarters · filed 2026-02-24 | $399.12M derived: sum of 3 quarters · filed 2026-02-24 | $513.52M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $140.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $258.43M derived: sum of 2 quarters · filed 2026-02-24 | $372.83M derived: sum of 3 quarters · filed 2026-02-24 | $483.60M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $118.41M 10-Q · filed 2024-10-30 | $232.81M derived: sum of 2 quarters · filed 2024-10-30 | $343.58M 10-Q · filed 2024-10-30 | $447.46M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $114.40M 10-Q · filed 2024-07-31 | $225.17M 10-Q · filed 2024-07-31 | $329.05M derived: sum of 3 quarters · filed 2025-02-26 | $423.54M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | $110.77M 10-Q · filed 2024-05-07 | $214.65M derived: sum of 2 quarters · filed 2025-02-26 | $309.14M derived: sum of 3 quarters · filed 2025-02-26 | $400.36M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | $103.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $198.36M derived: sum of 2 quarters · filed 2025-02-26 | $289.59M derived: sum of 3 quarters · filed 2025-02-26 | $380.03M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | $94.49M 10-Q · filed 2023-11-06 | $185.71M derived: sum of 2 quarters · filed 2023-11-06 | $276.16M 10-Q · filed 2023-11-06 | $359.52M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-06-30 | $91.22M 10-Q · filed 2023-08-03 | $181.67M 10-Q · filed 2023-08-03 | $265.03M derived: sum of 3 quarters · filed 2024-02-27 | $339.77M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-03-31 | $90.44M 10-Q · filed 2023-05-04 | $173.81M derived: sum of 2 quarters · filed 2024-02-27 | $248.54M derived: sum of 3 quarters · filed 2024-02-27 | $325.36M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | $83.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $158.10M derived: sum of 2 quarters · filed 2024-02-27 | $234.92M derived: sum of 3 quarters · filed 2024-02-27 | $285.82M 10-K · filed 2024-02-27 | ||||
| 2021-09-30 | $74.73M 10-Q · filed 2022-11-03 | $151.55M derived: sum of 2 quarters · filed 2022-11-03 | $202.46M 10-Q · filed 2022-11-03 | $250.88M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $76.82M 10-Q · filed 2022-08-04 | $127.72M 10-Q · filed 2022-08-04 | $176.15M derived: sum of 3 quarters · filed 2023-02-28 | $218.25M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $50.90M 10-Q · filed 2022-05-05 | $99.33M derived: sum of 2 quarters · filed 2023-02-28 | $141.43M derived: sum of 3 quarters · filed 2023-02-28 | $173.43M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $48.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $90.53M derived: sum of 2 quarters · filed 2023-02-28 | $122.53M derived: sum of 3 quarters · filed 2023-02-28 | $161.36M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $42.10M 10-Q · filed 2021-11-04 | $74.10M derived: sum of 2 quarters · filed 2021-11-04 | $112.94M 10-Q · filed 2021-11-04 | $149.64M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $32.00M 10-Q · filed 2021-08-03 | $70.84M 10-Q · filed 2021-08-03 | $107.55M derived: sum of 3 quarters · filed 2021-08-03 | $139.07M derived: sum of 4 quarters · filed 2021-08-03 | ||||
| 2020-03-31 | $38.84M 10-Q · filed 2021-05-06 | $75.55M derived: sum of 2 quarters · filed 2021-05-06 | $107.08M derived: sum of 3 quarters · filed 2021-05-06 | $136.38M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $36.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $68.24M derived: sum of 2 quarters · filed 2021-03-05 | $97.54M derived: sum of 3 quarters · filed 2021-03-05 | $124.87M 10-K · filed 2021-03-05 | ||||
| 2019-09-30 | $31.53M 10-Q · filed 2020-11-05 | $60.83M derived: sum of 2 quarters · filed 2020-11-05 | $88.16M 10-Q · filed 2020-11-05 | $112.43M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $29.30M 10-Q · filed 2020-08-06 | $56.63M 10-Q · filed 2020-08-06 | $80.90M derived: sum of 3 quarters · filed 2020-08-06 | $104.64M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $27.33M 10-Q · filed 2020-05-11 | $51.60M derived: sum of 2 quarters · filed 2020-05-11 | $75.34M derived: sum of 3 quarters · filed 2020-05-11 | $97.44M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $24.27M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $48.01M derived: sum of 2 quarters · filed 2020-03-17 | $70.11M derived: sum of 3 quarters · filed 2020-03-17 | $85.68M 10-K · filed 2020-03-17 | ||||
| 2018-09-30 | $23.74M 10-Q · filed 2019-11-01 | $22.45M 10-Q · filed 2018-11-09 | $45.84M derived: sum of 2 quarters · filed 2019-11-01 | $61.41M 10-Q · filed 2019-11-01 | $57.50M 10-Q · filed 2018-11-09 | $86.20M derived: sum of 4 quarters · filed 2019-11-01 | ||
| 2018-06-30 | $22.10M 10-Q · filed 2019-07-26 | $20.82M 10-Q · filed 2018-08-03 | $37.67M 10-Q · filed 2019-07-26 | $35.05M 10-Q · filed 2018-08-03 | $62.46M derived: sum of 3 quarters · filed 2019-07-26 | $78.23M derived: sum of 4 quarters · filed 2019-07-26 | ||
| 2018-03-31 | $15.57M 10-Q · filed 2019-05-10 | $14.24M 10-Q · filed 2018-05-11 | $40.36M derived: sum of 2 quarters · filed 2019-05-10 | $56.14M derived: sum of 3 quarters · filed 2019-05-10 | $72.62M derived: sum of 4 quarters · filed 2019-05-10 | |||
| 2017-12-31 | $24.79M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $40.56M derived: sum of 2 quarters · filed 2019-03-29 | $57.05M derived: sum of 3 quarters · filed 2019-03-29 | $77.22M 10-K · filed 2019-03-29 | $71.34M 10-K · filed 2018-03-09 | |||
| 2017-09-30 | $15.77M 10-Q · filed 2018-11-09 | $32.26M derived: sum of 2 quarters · filed 2018-11-09 | $52.43M 10-Q · filed 2018-11-09 | $74.13M derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | $16.48M 10-Q · filed 2018-08-03 | $36.66M 10-Q · filed 2018-08-03 | $58.35M derived: sum of 3 quarters · filed 2018-08-03 | $78.76M derived: sum of 4 quarters · filed 2018-08-03 | ||||
| 2017-03-31 | $20.18M 10-Q · filed 2018-05-11 | $41.87M derived: sum of 2 quarters · filed 2018-05-11 | $62.28M derived: sum of 3 quarters · filed 2018-05-11 | $83.76M derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | $21.69M 10-K · filed 2017-03-31 | $42.10M derived: sum of 2 quarters · filed 2017-11-09 | $63.58M derived: sum of 3 quarters · filed 2017-11-09 | $91.51M 10-K · filed 2018-03-09 | ||||
| 2016-09-30 | $20.41M 10-Q · filed 2017-11-09 | $41.89M derived: sum of 2 quarters · filed 2017-11-09 | $69.82M 10-Q · filed 2017-11-09 | $98.92M derived: sum of 4 quarters · filed 2017-11-09 | ||||
| 2016-06-30 | $21.48M 10-Q · filed 2017-08-11 | $29.08M 10-Q · filed 2016-08-09 | $49.41M 10-Q · filed 2017-08-11 | $63.69M 10-Q · filed 2016-08-09 | $78.51M derived: sum of 3 quarters · filed 2017-08-11 | $264.84M derived: sum of 4 quarters · filed 2017-08-11 | ||
| 2016-03-31 | $27.93M 10-Q · filed 2017-05-12 | $34.61M 10-Q · filed 2016-05-06 | $57.03M derived: sum of 2 quarters · filed 2017-05-12 | $243.37M derived: sum of 3 quarters · filed 2017-05-12 | $267.06M derived: sum of 4 quarters · filed 2017-05-12 | |||
| 2015-12-31 | $29.10M 10-K · filed 2017-03-31 | $36.94M 10-K · filed 2016-03-15 | $215.44M derived: sum of 2 quarters · filed 2017-03-31 | $239.13M derived: sum of 3 quarters · filed 2017-03-31 | $263.88M 10-K · filed 2017-03-31 | $292.52M 10-K · filed 2016-03-15 | ||
| 2015-09-30 | $186.33M 10-K · filed 2017-03-31 | $193.43M 10-Q · filed 2015-11-03 | $210.02M derived: sum of 2 quarters · filed 2017-03-31 | $234.76M 10-Q · filed 2016-11-09 | $255.58M 10-Q · filed 2015-11-03 | $269.49M derived: sum of 4 quarters · filed 2017-03-31 | ||
| 2015-06-30 | $23.69M 10-K · filed 2017-03-31 | $30.35M 10-Q · filed 2015-08-04 | $62.16M 10-Q · filed 2016-08-09 | $83.16M derived: sum of 3 quarters · filed 2017-03-31 | $117.73M derived: sum of 4 quarters · filed 2017-03-31 | |||
| 2015-03-31 | $24.75M 10-K · filed 2017-03-31 | $31.80M 10-Q · filed 2015-05-01 | $59.47M derived: sum of 2 quarters · filed 2017-03-31 | $94.04M derived: sum of 3 quarters · filed 2017-03-31 | $128.32M derived: sum of 4 quarters · filed 2017-03-31 | |||
| 2014-12-31 | $34.72M 10-K · filed 2016-03-15 | $69.29M derived: sum of 2 quarters · filed 2016-03-15 | $103.57M derived: sum of 3 quarters · filed 2016-03-15 | $108.18M 10-K · filed 2017-03-31 | $141.57M 10-K · filed 2015-02-27 | |||
| 2014-09-30 | $34.57M 10-K · filed 2016-03-15 | $68.85M derived: sum of 2 quarters · filed 2016-03-15 | $106.85M 10-Q · filed 2016-02-10 | $198.11M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-06-30 | $34.28M 10-K · filed 2016-03-15 | $72.28M 10-Q · filed 2016-02-10 | $163.53M derived: sum of 3 quarters · filed 2016-03-15 | $200.94M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-03-31 | $38.00M 10-K · filed 2016-03-15 | $129.25M derived: sum of 2 quarters · filed 2016-03-15 | $166.66M derived: sum of 3 quarters · filed 2016-03-15 | $201.65M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | $91.26M 10-K · filed 2015-02-27 | $128.66M derived: sum of 2 quarters · filed 2015-02-27 | $163.66M derived: sum of 3 quarters · filed 2015-02-27 | $197.75M 10-K · filed 2016-03-15 | ||||
| 2013-09-30 | $37.41M 10-K · filed 2015-02-27 | $72.40M derived: sum of 2 quarters · filed 2015-02-27 | $106.50M 10-Q · filed 2014-10-30 | $142.61M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $34.99M 10-K · filed 2015-02-27 | $69.09M 10-Q · filed 2014-07-31 | $105.20M derived: sum of 3 quarters · filed 2015-02-27 | $136.81M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $34.10M 10-K · filed 2015-02-27 | $70.21M derived: sum of 2 quarters · filed 2015-02-27 | $101.81M derived: sum of 3 quarters · filed 2015-02-27 | $135.76M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $36.11M 10-K · filed 2014-03-20 | $67.71M derived: sum of 2 quarters · filed 2014-03-20 | $101.66M derived: sum of 3 quarters · filed 2014-03-20 | $133.60M 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $31.61M 10-K · filed 2014-03-20 | $31.61M 10-Q · filed 2012-11-06 | $65.55M derived: sum of 2 quarters · filed 2014-03-20 | $97.50M 10-Q · filed 2013-11-12 | $138.90M derived: sum of 4 quarters · filed 2014-03-20 | |||
| 2012-06-30 | $33.95M 10-K · filed 2014-03-20 | $65.89M 10-Q · filed 2013-08-07 | $107.29M derived: sum of 3 quarters · filed 2014-03-20 | $139.86M derived: sum of 4 quarters · filed 2014-03-20 | ||||
| 2012-03-31 | $31.94M 10-K · filed 2014-03-20 | $31.95M 10-Q · filed 2012-05-08 | $73.34M derived: sum of 2 quarters · filed 2014-03-20 | $105.91M derived: sum of 3 quarters · filed 2014-03-20 | $139.08M derived: sum of 4 quarters · filed 2014-03-20 | |||
| 2011-12-31 | $41.40M 10-K · filed 2013-03-05 | $73.97M derived: sum of 2 quarters · filed 2013-03-05 | $107.13M derived: sum of 3 quarters · filed 2013-03-05 | $141.45M 10-K · filed 2014-03-20 | ||||
| 2011-09-30 | $32.57M 10-K · filed 2013-03-05 | $65.73M derived: sum of 2 quarters · filed 2013-03-05 | $100.05M 10-Q · filed 2012-11-06 | $133.23M derived: sum of 4 quarters · filed 2013-03-05 | ||||
| 2011-06-30 | $33.16M 10-K · filed 2013-03-05 | $67.48M 10-Q · filed 2012-08-08 | $100.66M derived: sum of 3 quarters · filed 2013-03-05 | $133.06M derived: sum of 4 quarters · filed 2013-03-05 | ||||
| 2011-03-31 | $34.31M 10-K · filed 2013-03-05 | $67.49M derived: sum of 2 quarters · filed 2013-03-05 | $99.89M derived: sum of 3 quarters · filed 2013-03-05 | $131.78M derived: sum of 4 quarters · filed 2013-03-05 | ||||
| 2010-12-31 | $33.18M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-05 | $65.58M derived: sum of 2 quarters · filed 2013-03-05 | $97.47M derived: sum of 3 quarters · filed 2013-03-05 | $124.61M 10-K · filed 2013-03-05 | ||||
| 2010-09-30 | $32.40M 10-Q · filed 2011-11-04 | $64.29M derived: sum of 2 quarters · filed 2011-11-04 | $91.43M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $31.89M 10-Q · filed 2011-08-08 | $59.02M 10-Q · filed 2011-08-08 | ||||||
| 2009-12-31 | $91.20M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |